Tuesday 29 September 2009
Hosted by: Clyde & Co LLP
Co-Organisers: Asia-Pacific Technology Network and the R&D Society
Chair:
- Professor Simon Collinson, Professor of International Business and Innovation, Warwick Business School.
Speakers
- Professor Simon Collinson, Professor of International Business and Innovation, Warwick Business School.
- "Foreign Direct Investment into and out of China: new trends and new challenges"
- Dr. Jackie Hunter Senior Vice President Science Environment Development GlaxoSmithKline R&D
- "Establishing a drug discovery facility in Singapore - the GSK experience"
- Professor Peter Williamson, Professor of International Management at Judge Business School and Fellow of Jesus College, University of Cambridge
- "Re-thinking Innovation in Recessionary Times: What We Might Learn From the Chinese Dragons?”
This seminar will ask questions about the nature of industrial research coming out of Asia and its direction, and the R&D roles companies should assign to the region. Chaired and introduced by Professor Simon Collinson, the seminar will examine the current state and future potential of R&D in China / Asia, both by local firms looking to internationalise and by foreign firms looking locate R&D activities in the region.
Location: Clyde & Co LLP 51 Eastcheap, London, EC3M 1JP
Map and Directions: Please Click Here
Nearest tube station: Monument
Timing: 17.30 - 19.30 - followed by refreshments
Pricing:
- Free to Clyde & Co clients and APTN/R&D Society annual subscribers
- £40 + VAT (Executives)
- £20 + VAT (Asian citizens/institutions, officials, executives from Small Companies)
- £10 + VAT (Academics)
- Free for the Media.
To Register your interest: please send your details (name, institutional affiliation, email address, phone number) to biz@aptn.org
The Asian Innovation seminar series is run by the Asia Pacific Technology Network (APTN) and the R&D Society. It covers the general area of "Asian Innovation". These seminars will range across sectors and countries within the region, and will focus on the issues thrown up by the emergence of world-class scientific centres in Asia.
- What kinds of innovation are we seeing in Asia? What is the balance between imitation (catch-up) and genuinely cutting edge innovation? ... and what other varieties of innovation are found in the region?
- What are the comparative paths to innovation taken by the various Asian countries?
- What are the barriers facing Asian innovators?
- What is the quality of the scientific and educational institutions underpinning the innovators?
- What contribution do entrepreneurs and venture capitalists make to the health of Asian innovation?
- How do Asian innovators interact with the innovation systems of Europe and the USA?
- Where are the most promising sectors for collaboration, and what are the areas of potential friction
Simon Collinson
Head of the Marketing and Strategic Management Group, Warwick Business School. Previously Lead Ghoshal Fellow in the ESRC/EPSRC-funded Advanced Institute of Management (AIM) and currently sits on the AIM Board of Directors. Simon has recently completed a three-year study of foreign multinational firms in China. He has held the role of Associate Dean (MBA) at WBS, was a visiting researcher at the NISTEP in Tokyo, Australia Graduate School of Management in Sydney, and visiting professor at the Kelley School of Business in Indiana. Awarded research funding from ESRC, the DTI Industrial Competitiveness Unit, the Royal Society and DGXII of the CEC. Research, consulting and executive teaching experience with firms such as ABB, British Aerospace, Corus, Diageo, HSBC, ICI, Lloyd's Register, Nippon Steel, Philips, Prudential and Sony..
Jackie Hunter
Dr Jackie Hunter has worked in the pharmaceutical industry for over 20 years, after carrying our post doctoral research at St George's Hospital Medical School in London. For most of her industrial career she has focussed on the discovery of drugs for serious neurological diseases such as Parkinson's disease, multiple sclerosis and Alzheimer's disease. She has worked for Glaxo, Smith Kline and French, SmithKline Beecham and is currently at GlaxoSmithKline based in the UK. In 2002 she was appointed Head of the Neurology and GI Centre of Excellence for Drug Discovery (CEDD). In this role she was responsible for 350 scientists (medicinal chemists, DMPK personnel and biologists) and clinicians based in the UK, USA and Singapore where she established a CEDD drug discovery and development unit. The CEDD was focussed on the discovery and development of new therapeutics for neurodegenerative disease, pain and gastrointestinal disorders. This resulted in over 15 proofs of concept in 5 years and several transitions to full development. In 2007 she was involved in the transfer of early phase neurodegeneration research to GSK's new research facility in China and remains a member of the Board of GW Manufacturing in Singapore. Dr Hunter has published over 130 scientific papers and served on a number of industrial and academic boards and is currently a member of the BBSRC council in the UK and a member of the Institute of Medicine's Drug Forum in the USA. In 2008 she moved to become Head of Science Environment Development with a remit to develop a pre-competitive research agenda and new ways of working with academia and other publically funded bodies globally.
Peter Williamson
Peter has been actively involved with business and research in Asia for more than two decades and in China since 1983. He has held professorships at London Business School, Harvard Business School and INSEAD (in Singapore). Formerly with The Boston Consulting Group, he serves on the boards of several companies. He holds a PhD in Business Economics from Harvard University.
His latest book, Dragons at Your Door: How Chinese cost innovation is disrupting global competition, was published by Harvard Business School Press in 2007. His other recent books include: Winning in Asia: Strategies for Competing in the New Millennium (2004) and From Global to Metanational: How Companies Win in the Knowledge Economy (2001). His article in the MIT Sloan Management Review “Is Your Innovation Process Global?” received a Sloan-Price Waterhouse Coopers Award honouring articles that have contributed most to the enhancement of management practice.